Henlius Partners With Amberstone on Next-Gen TCEs
Shanghai, China, September 24, 2026 Henlius has announced a strategic partnership with Amberstone Biosciences to discover and develop next-generation...
Henlius
Advertisement
DarioHealth and Beluga Partner to Transform Digital Chronic Care
NEW YORK, June 29, 2026 DarioHealth Corp. has announced a strategic collaboration with Beluga Health to create a provider-backed,...
Organon Launches BILDYOS® and TUZEMTY® in Canada
KIRKLAND, Quebec, Canada & SHANGHAI, China, June 23, 2026 Organon Canada and Shanghai Henlius Biotech have expanded access to...
Alligator Reports Global Phase 3 Progress for HLX22
LUND, Sweden, June 8, 2026 Alligator Bioscience announced a significant development in the ongoing global Phase 3 clinical trial...
Henlius Wins CHMP Support for Serplulimab in Lung Cancer
Shanghai, China, May 23, 2026 Henlius Biotech has announced that the Committee for Medicinal Products for Human Use (CHMP)...
Advertisements
Henlius and Organon Secure EU Approval for POHERDY®
SHANGHAI, China & JERSEY CITY, N.J., April 29, 2026 Shanghai Henlius Biotech, Inc. and Organon have announced that the...
Henlius Secures NMPA IND for HLX319 Breast Cancer Drug
SHANGHAI, China, April 1, 2026 Shanghai Henlius Biotech, Inc. announced that the China National Medical Products Administration (NMPA) has...
European Commission Approves Henlius and Organon’s Biosimilars for Bone Disorders
SHANGHAI, China & JERSEY CITY, NJ – September 19, 2025, Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN)...
Advertisement
